BioTalk is a news hub brought to you by Bird & Bird's International Life Sciences & Healthcare Group. Read more about us >

Posts with tag IP

Sort by Latest
First medicinal cannabis drug listed on the Australian Pharmaceuticals Benefits Scheme
On 1 May 2021 Epidyolex, the first medicinal cannabis drug product was listed on the Pharmaceutical Benefits Scheme (PBS). The costs of drug products listed on the PBS are subsidised by the Australian Government. Epidyolex is used in combination with at least two other anti-epileptic medicines to treat Dravet syndrome – a genetic epileptic disease that gives rise to seizures that doesn’t respond well to standard medications. While Epidyolex is the second medicinal cannabis drug registered for...
May 6, 2021
1 min read
Illumina v MGI: Patents Court gives guidance on the...
In Illumina v Latvia MGI Tech (MGI) [2021]...
March 26, 2021
9 min read
Introduction of the Narcotic Drugs Amendment (Medicinal...
On the 3rd February 2021, the Narcotic Drugs Amendment (Medicinal...
March 2, 2021
1 min read
Australian Courts apply “European Support” test to...
In the recent decision in the Australian front of the...
November 4, 2020
10 min read
The English Patents Court examines the law on enablement in the context of lack of novelty based on both prior publication and prior use.
Earlier this year (17 July 2019) in Takeda UK Limited v F. Hoffmann-La Roche AG Mr Justice Colin Birss...
November 19, 2019
5 min read
Cookie consent
We use analytics cookies to help us understand if our website is working well and to learn what content is most useful to visitors. We also use some cookies which are essential to make our website work. You can accept or reject our analytic cookies (including the collection of associated data) and change your mind at any time. Find out more in our Cookie Notice.